Ryan Hudson
62Patents
9h-index
37Co-inventors
74Inventor score
Filing activity: Jan 31, 2008 → Apr 5, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8563512B2 | Neprilysin inhibitors | Emerging Cross-Sectional Technologies | 63 | Active |
| US7777077B2 | Dual-acting antihypertensive agents | Chemistry; Metallurgy | 29 | Active |
| US7834041B2 | Dual-acting antihypertensive agents | Chemistry; Metallurgy | 27 | Active |
| US7956054B2 | Dual-acting pyrazole antihypertensive agents | Chemistry; Metallurgy | 20 | Active |
| US9725470B2 | Substituted naphthyridines as JAK kinase inhibitors | Chemistry; Metallurgy | 19 | Active |
| US10028960B2 | Pyrimidine compounds as JAK kinase inhibitors | Chemistry; Metallurgy | 16 | Active |
| US8372984B2 | Dual-acting oxazole antihypertensive agents | Chemistry; Metallurgy | 14 | Active |
| US10140625B2 | Systems and methods for interfacing with a website to modify content | Physics | 13 | Active |
| US10308646B2 | Pyrimidine compound as JAK kinase inhibitor | Chemistry; Metallurgy | 9 | Active |
| US10562894B2 | Pyrimidine compound as JAK kinase inhibitor | Chemistry; Metallurgy | 7 | Active |
| US10774080B2 | Pyrimidine compound as JAK kinase inhibitor | Chemistry; Metallurgy | 5 | Active |
| US8119634B2 | Dual-acting pyrazole antihypertensive agents | Chemistry; Metallurgy | 5 | Active |
| US10679233B2 | Systems and methods for interfacing with a website to modify content | Physics | 5 | Active |
| US9120758B2 | Neprilysin inhibitors | Emerging Cross-Sectional Technologies | 4 | Active |
| US10988470B2 | Pyrimidine compound as JAK kinase inhibitor | Chemistry; Metallurgy | 3 | Active |
| US9555041B2 | Neprilysin inhibitors | Emerging Cross-Sectional Technologies | 3 | Active |
| US11110095B2 | Pyrimidine compounds as JAK kinase inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10870652B2 | Compounds and methods for modulating bruton's tyrosine kinase | Chemistry; Metallurgy | 2 | Active |
| US11420965B2 | Pyrimidine compound as JAK kinase inhibitor | Chemistry; Metallurgy | 2 | Active |
| US10685368B1 | Systems and methods for interfacing with a website to modify content | Physics | 2 | Active |
| US10719843B2 | Systems and methods for interfacing with a website to modify content | Physics | 2 | Active |
| US10726437B2 | Systems and methods for interfacing with a website to modify content | Physics | 2 | Active |
| US10947254B2 | Methods for treating ulcerative colitis using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile | Chemistry; Metallurgy | 2 | Active |
| US11780852B2 | Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile | Chemistry; Metallurgy | 2 | Active |
| US8106082B2 | Dual-acting antihypertensive agents | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.